TGA fines JSHealth for ‘unlawful advertising’
Health and wellness brand JSHealth has been fined $26,640 for alleged “unlawful use of restricted and prohibited representations” by The Therapeutic Goods Administration.
But the company claims the penalty has arisen from a misunderstanding.
The TGA says the brand’s advertising included claims such as its ability to treat serious health conditions like cancer and Alzheimer’s, without obtaining prior permission from the regulator.
However, on Instagram, the company said news articles about the fine have “misconstrued the situation” adding: “It was never our intention to suggest that those studies relate to our formula itself, but simply the ingredient C3 extract alone.”
A blog by the brand mentioned the benefits of its Turmeric+ formula, citing the research behind the use of C3 extract, an isolated ingredient used because it was “interesting”.
“We are passionate about ensuring our formulas meet strict guidelines and only use permitted health claims. Behind the scenes of JSHealth, you would appreciate just how seriously we take this as a business. Abiding by the regulatory law is a top priority.”
JSHealth was launched in 2019 by Jessica Sepel, pictured above, a clinical nutritionist by trade, alongside her husband Dean, who is CEO.
The brand’s portfolio includes 48 products across supplements, skincare, haircare and plant-based powders. It is sold in 408 stores nationwide.
The post TGA fines JSHealth for ‘unlawful advertising’ appeared first on Inside Retail.